Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Qun‐Ling Zhang"'
Publikováno v:
Clinical and Translational Discovery, Vol 4, Iss 5, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/95207df7df6046d2a71bdce653e57807
Autor:
Di Shi, Lin Gao, Xiao-Chun Wan, Jin Li, Tian Tian, Jue Hu, Qun-Ling Zhang, Yi-Fan Su, Yu-Peng Zeng, Zi-Juan Hu, Bao-Hua Yu, Xiao-Qiu Li, Ping Wei, Ji-Wei Li, Xiao-Yan Zhou
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Plasmablastic lymphoma (PBL) is a rare but aggressive B-cell lymphoma subtype with poor prognosis. Knowledge about the etiology, clinicopathologic and molecular features, and outcomes of PBL is limited. This study aimed to examine
Externí odkaz:
https://doaj.org/article/29e1c29f8f2a4010985723e7e45fc918
Autor:
Kai Xue, Ji-Chuan Wu, Xi-Ya Li, Ran Li, Qun-ling Zhang, Jin-Jia Chang, Yi-Zhen Liu, Chun-Hui Xu, Jia-Ying Zhang, Xiao-Jian Sun, Juan J. Gu, Wei-Jian Guo, Lan Wang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 10, Pp 1-11 (2021)
Abstract Rituximab/chemotherapy relapsed and refractory B cell lymphoma patients have a poor overall prognosis, and it is urgent to develop novel drugs for improving the therapy outcomes. Here, we examined the therapeutic effects of chidamide, a new
Externí odkaz:
https://doaj.org/article/01cbf1d04174447286c96ab3ad4ae816
Autor:
Ji-Wei Li, Di Shi, Xiao-Chun Wan, Jue Hu, Yi-Fan Su, Yu-Peng Zeng, Zi-Juan Hu, Bao-Hua Yu, Qun-Ling Zhang, Ping Wei, Xiao-Yan Zhou
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Plasma extracellular vesicles (EVs) have been reported to be a promising source of diagnostic and prognostic biomarkers in various cancers. However, further research in this area is needed due to the limitations of circulating extracellular vesicles
Externí odkaz:
https://doaj.org/article/8b558ba7f82c4d53970fe304f5188d8c
Autor:
Xi-Ya Li, Ji-Chuan Wu, Ping Liu, Zi-Juan Li, Yong Wang, Bing-Yi Chen, Cheng-Long Hu, Ming-Yue Fei, Peng-Cheng Yu, Yi-Lun Jiang, Chun-Hui Xu, Bin-He Chang, Xin-Chi Chen, Li-Juan Zong, Jia-Ying Zhang, Ying Fang, Xiao-Jian Sun, Kai Xue, Li Wang, Shu-Bei Chen, Shi-Yu Jiang, Ai-ling Gui, Ling Yang, Juan J. Gu, Bao-Hua Yu, Qun-ling Zhang, Lan Wang
Publikováno v:
Leukemia.
The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy for these patients is urgently needed. Although ubiquitin-specific protease 1 (USP1) plays a key role
Autor:
Yu-Ting Dai, Fan Zhang, Hai Fang, Jian-Feng Li, Gang Lu, Lu Jiang, Bing Chen, Dong-Dong Mao, Yuan-Fang Liu, Jin Wang, Li-Jun Peng, Chong Feng, Hai-Feng Chen, Jun-Xi Mu, Qun-Ling Zhang, Hao Wang, Hany Ariffin, Tan Ah Moy, Jing-Han Wang, Yin-Jun Lou, Su-Ning Chen, Qian Wang, Hong Liu, Zhe Shan, Itaru Matsumura, Yasushi Miyazaki, Takahiko Yasuda, Li-Ping Dou, Xiao-Jing Yan, Jin-Song Yan, Allen Eng-Juh Yeoh, De-Pei Wu, Hitoshi Kiyoi, Fumihiko Hayakawa, Jie Jin, Sheng-Yue Wang, Xiao-Jian Sun, Jian-Qing Mi, Zhu Chen, Jin-Yan Huang, Sai-Juan Chen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 119(15)
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy of T cell progenitors, known to be a heterogeneous disease in pediatric and adult patients. Here we attempted to better understand the disease at the molecular leve
Autor:
Chun-Hui Xu, Xi-Ya Li, Xiao-Jian Sun, Lan Wang, Ran Li, Kai Xue, Jia Ying Zhang, Jin-Jia Chang, Wei-Jian Guo, Ji-Chuan Wu, Qun-Ling Zhang, Juan J Gu, Yizhen Liu
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 10, Pp 1-11 (2021)
Cell Death and Disease, Vol 12, Iss 10, Pp 1-11 (2021)
Rituximab/chemotherapy relapsed and refractory B cell lymphoma patients have a poor overall prognosis, and it is urgent to develop novel drugs for improving the therapy outcomes. Here, we examined the therapeutic effects of chidamide, a new histone d
Autor:
Xiaoyan Zhou, Xiao-Chun Wan, Qun-Ling Zhang, Zi-Juan Hu, Yi-Fan Su, Baohua Yu, Jiwei Li, Jue Hu, Yu-Peng Zeng, Di Shi, Ping Wei
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
Plasma extracellular vesicles (EVs) have been reported to be a promising source of diagnostic and prognostic biomarkers in various cancers. However, further research in this area is needed due to the limitations of circulating extracellular vesicles
Autor:
Qun Ling Zhang, Chun Yan Li, Xiao Jian Liu, Bo Shi Wang, Yi Zhen Liu, Xiaonan Hong, Jiachen Wang, Hui Sun, Zu Guang Xia, Jun Ning Cao, Dong Mei Ji, Jia Jin, Kai Xue, Fang Fang Lv
Publikováno v:
Leukemia & Lymphoma. 60:934-939
Diffuse large B cell lymphoma is one of the predominant histological subtypes of primary gastric lymphomas. Factors that contribute to precise stratification and guide the treatment of this disease are still not well understood. We analyzed 73 primar
Autor:
Ji Chuan Wu, Peng Cheng Yu, Zhu Chen, Li Juan Zong, Chun Hui Xu, Na Liu, Ping Liu, Shu Bei Chen, Stephen D. Nimer, Jia Ying Zhang, Ming Sun, Yuan Liang Zhang, Cheng Long Hu, Bing Yi Chen, Ruo Fei Dai, Dan Hou, Sai Juan Chen, Qiu Hua Huang, Junhong Song, Fei Lan, Su Jiang Zhang, Qun-Ling Zhang, Xiao-Jian Sun, Lan Wang
Publikováno v:
Blood
SETD2, the histone H3 lysine 36 methyltransferase, previously identified by us, plays an important role in the pathogenesis of hematologic malignancies, but its role in myelodysplastic syndromes (MDSs) has been unclear. In this study, low expression